Answers are grounded in this paper and cite their sources.
This study demonstrates the bacteriolytic activity of human lactoferrin on intact cells. We investigated the effects of pH, ionic strength, and low-molecular-weight compounds – including amino acids, oligopeptides, and the nonionic surfactant Tween-21 – in modulating this lytic activity. The combined bacteriolytic action of lactoferrin and lysozyme was also investigated. Charged amino acids (Arg, His, Glu) and Gly at 1–5 mM enhanced LTF-mediated lysis 2.2- to 4.5-fold. The non-ionic surfactant Tween-21 (0.1–0.2 µM) enhanced LTF activity 3.2-fold. A panel of structurally diverse oligopeptides and small molecules – selected based on their charge, conformation, and amphipathic profiles – was evaluated for LTF-modulating activity. Antimicrobial and regulatory peptides – including bacitracin, the synthetic hexapeptide imunofan, and the heptapeptide semax (MEHFPGP) – at micromolar concentrations synergistically amplified LTF lytic activity up to 12-fold. The cyclic peptide gramicidin S, the macrocyclic lactone ivermectin, and the regulatory peptides dalargin and selank exhibited intrinsic bacteriolytic activity against , but they did not enhance bacteriolytic activity of LTF. LTF and lysozyme act synergistically: their combined lytic rate is twofold higher than the calculated additive effect, suggesting a sequential or cooperative disruption of the cell envelope. These findings expand the understanding of LTF as a direct lytic agent and elucidate that small-molecule effectors can modulate the physiological efficacy of cationic host-defense proteins.
No takes yet. Share an insight, caveat, or question.
Klimov et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: